Borana Weaves IPO is set for listing on May 27, following a successful subscription period from May 20 to 22. The IPO ...

Bora Biologics, a contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, is ...

Belrise Industries IPO price band is set at ₹85 to ₹90 per share. At the upper-end of the price band, the company plans to ...

The non-institutional investors (NII) overtook retail investors by booking their reserved portion by a whopping 20.23 times.

Scorpius plans to utilize its scientific and technical expertise to validate the commercial manufacturing process for Tivic’s lead candidate, Entolimod™. The GMP Validation Program is valued ...

Belrise Industries' IPO is launching soon. The IPO price is fixed at Rs 85-90 per share. The IPO has a grey market premium of ...

CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, has chosen CELLforCURE by SEQENS, as ...

Explore Lineage Cell Therapeutics' Q1 2025 insights, including OpRegen progress, a manufacturing milestone, key clinical data, and a strong financial outlook.

The unlisted shares of Accretion Pharmaceuticals were trading at ₹113, commanding a GMP of ₹12 or 11.88 per cent against the ...